Cite
HARVARD Citation
Stürner, K. et al. (2018). A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial). Journal of neurology, neurosurgery and psychiatry. 89 (4), pp. 330-338. [Online].